argenx SE

268.98+5.73+2.18%Vol 234.06K1Y Perf 94.15%
Apr 13th, 2021 16:00 DELAYED
BID268.56 ASK269.00
Open271.35 Previous Close263.25
Pre-Market- After-Market-
 - -  - -%
Target Price
335.23 
Analyst Rating
Strong Buy 1.21
Potential %
24.63 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.80
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     62.15
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap13.80B 
Earnings Rating
Sell
Price Range Ratio 52W %
55.12 
Earnings Date
13th May 2021

Today's Price Range

266.34275.14

52W Range

130.00382.15

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.88%
1 Month
-13.42%
3 Months
-4.67%
6 Months
-2.87%
1 Year
94.15%
3 Years
217.34%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ARGX268.985.73002.18
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
6.10
6.30
0.00
0.01
-371.10
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
-
-628.90
-623.10
-500.00
-
RevenueValueIndustryS&P 500US Markets
44.17M
0.86
15.11
46.33
Earnings HistoryEstimateReportedSurprise %
Q04 2020-2.89-4.20-45.33
Q03 2020-2.80-3.96-41.43
Q02 2020-2.55-3.15-23.53
Q01 2020-1.88-2.06-9.57
----
----
----
----
Earnings Per EndEstimateRevision %Trend
3/2021 QR-3.15-5.70Negative
6/2021 QR-4.33-21.97Negative
12/2021 FY-16.30-25.77Negative
12/2022 FY-15.87-52.30Negative
Next Report Date13th May 2021
Estimated EPS Next Report-3.15
Estimates Count7
EPS Growth Next 5 Years %-
Volume Overview
Volume234.06K
Shares Outstanding51.31M
Trades Count4.55K
Dollar Volume63.17M
Avg. Volume207.15K
Avg. Weekly Volume176.28K
Avg. Monthly Volume188.22K
Avg. Quarterly Volume213.73K

argenx SE (NASDAQ: ARGX) stock closed at 268.98 per share at the end of the most recent trading day (a 2.18% change compared to the prior day closing price) with a volume of 234.20K shares and market capitalization of 13.80B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 188 people. argenx SE CEO is Tim Van Hauwermeiren.

The one-year performance of argenx SE stock is 94.15%, while year-to-date (YTD) performance is -8.54%. ARGX stock has a five-year performance of %. Its 52-week range is between 130 and 382.15, which gives ARGX stock a 52-week price range ratio of 55.12%

argenx SE currently has a PE ratio of -19.90, a price-to-book (PB) ratio of 8.90, a price-to-sale (PS) ratio of 305.77, a price to cashflow ratio of 57.40, a PEG ratio of 2.32, a ROA of -32.14%, a ROC of -28.09% and a ROE of -43.80%. The company’s profit margin is -%, its EBITDA margin is -623.10%, and its revenue ttm is $44.17 Million , which makes it $0.86 revenue per share.

Of the last four earnings reports from argenx SE, there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-3.15 for the next earnings report. argenx SE’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for argenx SE is Strong Buy (1.21), with a target price of $335.23, which is +24.63% compared to the current price. The earnings rating for argenx SE stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

argenx SE has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

argenx SE has a Sell technical analysis rating based on Technical Indicators (ADX : 16.32, ATR14 : 15.69, CCI20 : -96.48, Chaikin Money Flow : -0.21, MACD : -13.86, Money Flow Index : 38.68, ROC : -8.34, RSI : 42.79, STOCH (14,3) : 18.87, STOCH RSI : 0.82, UO : 40.39, Williams %R : -81.13), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of argenx SE in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (83.33 %)
9 (81.82 %)
9 (81.82 %)
Moderate Buy
1 (8.33 %)
1 (9.09 %)
1 (9.09 %)
Hold
1 (8.33 %)
1 (9.09 %)
1 (9.09 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.21
Strong Buy
1.23
Strong Buy
1.23

argenx SE

argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-111, ARGX-109, ARGX-115, ARGX-112, and others. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Switzerland.

CEO: Tim Van Hauwermeiren

Telephone: +31 763030488

Address: Willemstraat 5, Breda 4811 AH, , NL

Number of employees: 188

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

48%52%

Bearish Bullish

62%38%

News

Stocktwits